Alignment Healthcare Reports Fourth Quarter and Full-Year 2025 Results; Beats High-End of Guidance Across All Key Metrics
Alignment Healthcare, Inc. (NASDAQ: ALHC) reported a robust fourth quarter and full-year financial performance for 2025, achieving total revenue of $3.95 billion, which marks a significant 46.1% increase year-over-year. The company exceeded the high-end of its guidance across all key metrics, including membership growth, revenue, adjusted gross profit, and adjusted EBITDA. Notably, health plan membership reached approximately 236,300, reflecting a 25% year-over-year increase, while adjusted EBITDA for the year was reported at $109.9 million, demonstrating a marked improvement in profitability and operational efficiency.
This performance aligns with Alignment Healthcare's strategic focus on expanding its Medicare Advantage offerings and enhancing its care model, which has been a recurring theme in previous announcements. The company has consistently articulated its commitment to delivering high-quality care while managing costs effectively. In its prior guidance, the company had indicated a strong trajectory for growth, and the latest results validate this outlook. The introduction of 2026 revenue guidance between $5.14 billion and $5.19 billion, representing a growth rate of 30% to 31% year-over-year, further underscores the company's momentum and operational scalability.
From a financial perspective, Alignment Healthcare's balance sheet appears solid, with the company generating free cash flow on a full-year basis for the first time, which is a critical indicator of financial health. The adjusted gross profit for the year was $494.8 million, and the medical benefits ratio based on adjusted gross profit was 87.5%, indicating effective management of medical costs relative to revenue. The company’s ability to maintain a net loss of only $1 million, down from a loss of $128 million in the previous year, highlights significant operational improvements and cost controls. The funding capacity appears adequate to support planned expenditures, particularly as the company continues to invest in its growth initiatives.
In terms of peer comparison, Alignment Healthcare operates within a competitive landscape that includes companies such as Clover Health Investments, Corp. (NASDAQ: CLOV), which focuses on Medicare Advantage plans and reported a revenue of $1.12 billion for 2025, reflecting a growth trajectory albeit at a smaller scale than Alignment. Another comparable entity is WellCare Health Plans, Inc. (NASDAQ: WCG), which has a more extensive membership base but operates in a similar Medicare-focused market. Additionally, Centene Corporation (NYSE: CNC) serves a large population in the Medicaid and Medicare sectors, showcasing a diversified approach to health care services, although it operates at a significantly larger scale than Alignment. These comparisons highlight Alignment's unique position as a mid-sized player with a strong growth narrative in a sector dominated by larger entities.
The significance of Alignment Healthcare's latest results cannot be overstated. The company’s ability to exceed guidance across all key metrics not only enhances its credibility in the market but also positions it favorably against its peers. The recognition on the 2026 Fortune World’s Most Admired Companies™ list further solidifies its reputation as an innovator in senior health care. As the company moves into 2026, the focus on disciplined growth and operational scalability is likely to drive long-term value creation for its members and shareholders alike. The projected growth in membership and revenue suggests that Alignment Healthcare is well on its way to establishing a more dominant presence in the Medicare Advantage market, which could lead to increased investor interest and potential valuation uplifts.